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Introduction: We sought to evaluate a new risk prediction tool (HARM Score) incorporating age with novel biomarkers against FRS for future CHD 
deaths risk prediction in a representative US population free of cardiovascular disease. 
Method: 2,922 participants (age >=40 years) in the Third National Health and Nutrition Examination Survey with information on microalbuminuria, 
homocysteine levels and red cell distribution width were studied. Regression coefficients based score points were assigned to Hyperhomocystenemia 
(>=15 micromol/L), elevated RDW (>=13.7), Microalbuminuria, and from an Age-adjusted multivariate regression analysis. The final score (HARM 
score) was derived summing up age with other score points for each individual. C-statistics and area under the curve (AUC) were compared for FRS 
and HARM Score at 5, 10-year and overall follow up duration. Participants analyzed according to categories of HARM score (very low risk: 20%) and 
FRS risk categories (low 20%) based on their estimated risk of CHD death. 
Results:  Graded increase in CHD deaths with increasing HARM score was observed [1.8% in very low vs. 8.1% in low, 16.5% in intermediate and 
23.2% in high risk groups] compared to FRS [1.5% in low risk vs. 10.9% in intermediate and 12.6% in high risk groups]. C-statistics and AUC were 
significantly higher for HARM score compared to FRS. 
Conclusion: HARM score outperforms FRS for incident CHD mortality risk prediction. 
